Non-infectious comorbidity in patients with multiple sclerosis: A national cohort study in Sweden von Castelo-Branco, Anna, Chiesa, Flaminia, Bengtsson, Camilla E, Lee, Sally, Minton, Neil N, Niemcryk, Steve, Lindholm, Anders, Rosenlund, Mats, Piehl, Fredrik, Montgomery, Scott

Volltext

Pharmacokinetic and Pharmacodynamic Modeling of Recombinant Human Erythropoietin After Single and Multiple Doses in Healthy Volunteers von Ramakrishnan, Rohini, Cheung, Wing K., Wacholtz, Mary C., Minton, Neil, Jusko, William J.

Volltext

Pregnancy outcomes in the ozanimod multiple sclerosis clinical development program (2432) von Minton, Neil, Henry, Alyssa, Janjua, Anne, Poli, Gandhi Reddy

Volltext

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial von Comi, Giancarlo, Kappos, Ludwig, Selmaj, Krzysztof W, Bar-Or, Amit, Arnold, Douglas L, Steinman, Lawrence, Hartung, Hans-Peter, Montalban, Xavier, Kubala Havrdová, Eva, Cree, Bruce A C, Sheffield, James K, Minton, Neil, Raghupathi, Kartik, Ding, Ning, Cohen, Jeffrey A

Volltext

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial von Cohen, Jeffrey A, Comi, Giancarlo, Selmaj, Krzysztof W, Bar-Or, Amit, Arnold, Douglas L, Steinman, Lawrence, Hartung, Hans-Peter, Montalban, Xavier, Kubala Havrdová, Eva, Cree, Bruce A C, Sheffield, James K, Minton, Neil, Raghupathi, Kartik, Huang, Vivian, Kappos, Ludwig

Volltext

Pharmacokinetic Considerations and Efficacy of Levofloxacin in an Inhalational Anthrax (Postexposure) Rhesus Monkey Model von KAO, L. Mark, BUSH, Karen, KELLEY, Michael F, BARNEWALL, Roy, ESTEP, James, THALACKER, Frederic W, OLSON, Pamela H, DRUSANO, George L, MINTON, Neil, CHIEN, Shuchean, HEMERYCK, Alex

Volltext

Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis von Dellon, Evan S., Collins, Margaret H., Rothenberg, Marc E., Assouline-Dayan, Yehudith, Evans, Larry, Gupta, Sandeep, Schoepfer, Alain, Straumann, Alex, Safroneeva, Ekaterina, Rodriguez, Cristian, Minton, Neil, Hua, Steven Y., Hirano, Ikuo

Volltext

Pregnancy Outcomes in the Ozanimod Nonclinical and Clinical Development Program (P4.363) von Campagnolo, Denise, Montero-Embalsado, Catherine, Meier-Davis, Susan, Minton, Neil

Volltext

Abstract 12690: Mavacamten Treatment in Patients With Obstructive and Nonobstructive Hypertrophic Cardiomyopathy: A Pooled Safety Analysis of 5 Clinical Trials von Fermin, David, Saberi, Sara, Abraham, Theodore P, Olivotto, Iacopo, Masri, Ahmad, Sehnert, Amy J, Minton, Neil, Fox, Shawna, Bach, Richard G

Volltext

Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study von Feagan, Brian G, Sandborn, William J, Danese, Silvio, Wolf, Douglas C, Liu, Wenzhong J, Hua, Steven Y, Minton, Neil, Olson, Allan, D'Haens, Geert

Volltext

Design of DISCOVER-HCM: A Registry of Real-world Treatment Patterns and Outcomes of Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy von Hernandez, Adrian, Masoudi, Frederick, Mazimba, Sula, Saberi, Sara, Setoguchi, Soko, Spertus, John, Shen, Sophie, Balaratnam, Ganesh, Chen, Yu-mao, Afsari, Sonia, Minton, Neil, Januzzi, James

Volltext

Multi-database study of multiple sclerosis: identification, validation and description of MS patients in two countries von Persson, Rebecca, Lee, Sally, Yood, Marianne Ulcickas, Wagner, Michael, Minton, Neil, Niemcryk, Steve, Lindholm, Anders, Evans, Amber, Jick, Susan

Volltext

Hepatic Safety of Ozanimod in Phase 3 Relapsing Multiple Sclerosis Trials (62) von Comi, Giancarlo, Selmaj, Krzystof, Bar-Or, Amit, Hartung, Hans-Peter, Havrdová, Eva Kubala, Sheffield, James, Minton, Neil, Afsari, Sonia, Liu, Hongjuan, Silva, Diego, Cohen, Jeffrey

Volltext

Incident cardiovascular disease in patients diagnosed with multiple sclerosis: A multi-database study von Persson, Rebecca, Lee, Sally, Yood, Marianne Ulcickas, Wagner, Michael, Minton, Neil, Niemcryk, Steve, Lindholm, Anders, Evans, Amber, Jick, Susan

Volltext

Increased Risk of Comorbidities in Patients Before and After Multiple Sclerosis Diagnosis and Initiation of Treatment: A Study Using the US Department of Defense Database (P4.2-058... von Persson, Rebecca, Yood, Marianne Ulcickas, Wagner, Michael, Evans, Amber, Lee, Sally, Minton, Neil, Niemcryk, Steve, Lindholm, Anders, Jick, Susan

Volltext

Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial von Cree, Bruce AC, Selmaj, Krzysztof W, Steinman, Lawrence, Comi, Giancarlo, Bar-Or, Amit, Arnold, Douglas L, Hartung, Hans-Peter, Montalbán, Xavier, Havrdová, Eva K, Sheffield, James K, Minton, Neil, Cheng, Chun-Yen, Silva, Diego, Kappos, Ludwig, Cohen, Jeffrey A

Volltext

Low Rate of Infections With Long-term Use of Ozanimod in Relapsing Multiple Sclerosis Trials (1596) von Hartung, Hans-Peter, Cree, Bruce A. C., Selmaj, Krzysztof W., Havrdová, Eva Kubala, Comi, Giancarlo, Sheffield, James K., Minton, Neil, Janjua, Anne, Ding, Ning, Bar-Or, Amit

Volltext

Infections in patients with multiple sclerosis: A national cohort study in Sweden von Castelo-Branco, Anna, Chiesa, Flaminia, Conte, Simona, Bengtsson, Camilla, Lee, Sally, Minton, Neil, Niemcryk, Steve, Lindholm, Anders, Rosenlund, Mats, Piehl, Fredrik, Montgomery, Scott

Volltext

Lenalidomide (LEN) and Epstein-Barr Virus (EBV) Reactivation von Mezo, Melinda, Bjorklund, Chad C., Weiss, Lilia, Minton, Neil, Freeman, John

Volltext

Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program von Selmaj, Krzysztof W., Cohen, Jeffrey A, Comi, Giancarlo, Bar-Or, Amit, Arnold, Douglas L, Steinman, Lawrence, Hartung, Hans Peter, Montalban, Xavier, Havrdova, Eva Kubala, Cree, Bruce A.C., Minton, Neil, Sheffield, James K, Ding, Ning, Kappos, Ludwig

Volltext